Catalyst
Slingshot members are tracking this event:
Rova-T (TRINITY) Phase 2 pivotal data in Third-line Small Cell Lung Cancer expected Q4 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ABBV | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 22, 2018
Occurred Source:
https://news.abbvie.com/news/abbvie-announces-results-from-phase-2-study-evaluating-rovalpituzumab-tesirine-rova-t-for-third-line-treatment-patients-with-dll3-expressing-relapsedrefractory-small-cell-lung-cancer.htm
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Trinity, Rova-t, Small Cell Lung Cancer
